High density lipoprotein complete list of trials: Revision history

21 October 2013

• curprev 14:2114:21, 21 October 2013‎ Rim Halaby talk contribs‎ 27,946 bytes +19‎ No edit summary

10 October 2013

• curprev 15:3015:30, 10 October 2013‎ Rim Halaby talk contribs‎ 27,927 bytes +282‎ →‎Niacin
• curprev 15:1715:17, 10 October 2013‎ Rim Halaby talk contribs‎ 27,645 bytes +500‎ →‎Niacin
• curprev 15:0815:08, 10 October 2013‎ Rim Halaby talk contribs‎ 27,145 bytes +429‎ →‎Niacin
• curprev 15:0315:03, 10 October 2013‎ Rim Halaby talk contribs‎ 26,716 bytes +147‎ →‎Niacin
• curprev 14:5714:57, 10 October 2013‎ Rim Halaby talk contribs‎ 26,569 bytes +277‎ →‎Niacin

23 September 2013

• curprev 15:1315:13, 23 September 2013‎ Hilda Mahmoudi talk contribs‎ 26,292 bytes −1,699‎ →‎Other trials
• curprev 15:1215:12, 23 September 2013‎ Hilda Mahmoudi talk contribs‎ 27,991 bytes +4‎ →‎CETP Inhibitors
• curprev 15:1015:10, 23 September 2013‎ Hilda Mahmoudi talk contribs‎ 27,987 bytes +1,591‎ →‎CETP Inhibitors

20 September 2013

• curprev 20:3520:35, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ 26,396 bytes +1‎ →‎Reconstituted HDL Infusion
• curprev 20:3420:34, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ 26,395 bytes 0‎ →‎CETP Inhibitors
• curprev 18:2118:21, 20 September 2013‎ Rim Halaby talk contribs‎ 26,395 bytes −3‎ →‎CETP Inhibitors
• curprev 18:2018:20, 20 September 2013‎ Rim Halaby talk contribs‎ 26,398 bytes −143‎ →‎CETP Inhibitors
• curprev 18:1918:19, 20 September 2013‎ Rim Halaby talk contribs‎ 26,541 bytes +14‎ →‎CETP Inhibitors
• curprev 18:0918:09, 20 September 2013‎ Rim Halaby talk contribs‎ 26,527 bytes +11‎ →‎CETP Inhibitors
• curprev 18:0718:07, 20 September 2013‎ Rim Halaby talk contribs‎ 26,516 bytes −3‎ →‎CETP Inhibitors
• curprev 18:0618:06, 20 September 2013‎ Rim Halaby talk contribs‎ 26,519 bytes +27‎ →‎CETP Inhibitors
• curprev 15:5015:50, 20 September 2013‎ Twinkle Singh talk contribs‎ 26,492 bytes +6‎ →‎CETP Inhibitors
• curprev 15:4715:47, 20 September 2013‎ Twinkle Singh talk contribs‎ 26,486 bytes +17‎ →‎CETP Inhibitors
• curprev 15:2315:23, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ 26,469 bytes +19‎ →‎Reconstituted HDL Infusion
• curprev 15:2215:22, 20 September 2013‎ Rim Halaby talk contribs‎ 26,450 bytes −197‎ →‎Reconstituted HDL Infusion
• curprev 15:2015:20, 20 September 2013‎ Twinkle Singh talk contribs‎ 26,647 bytes +6‎ →‎CETP Inhibitors
• curprev 15:1815:18, 20 September 2013‎ Twinkle Singh talk contribs‎ 26,641 bytes +15‎ →‎CETP Inhibitors
• curprev 14:3914:39, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ 26,626 bytes −369‎ →‎CETP Inhibitors
• curprev 14:3414:34, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ 26,995 bytes +25‎ →‎Reconstituted HDL Infusion
• curprev 14:3114:31, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ 26,970 bytes −4‎ →‎Reconstituted HDL Infusion
• curprev 14:3014:30, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ 26,974 bytes −23‎ →‎Reconstituted HDL Infusion
• curprev 14:2814:28, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ 26,997 bytes −1‎ →‎Reconstituted HDL Infusion
• curprev 14:2714:27, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ 26,998 bytes −17‎ →‎Reconstituted HDL Infusion
• curprev 14:2614:26, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ 27,015 bytes +85‎ →‎Reconstituted HDL Infusion
• curprev 14:1114:11, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ 26,930 bytes +6‎ →‎Reconstituted HDL Infusion
• curprev 14:0614:06, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ 26,924 bytes +237‎ →‎Reconstituted HDL Infusion
• curprev 13:5413:54, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ 26,687 bytes +194‎ →‎Reconstituted HDL Infusion
• curprev 13:4413:44, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ 26,493 bytes +41‎ →‎Reconstituted HDL Infusion
• curprev 13:4113:41, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ 26,452 bytes +607‎ →‎Reconstituted HDL Infusion
• curprev 13:3213:32, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ 25,845 bytes +37‎ →‎Reconstituted HDL Infusion
• curprev 13:3013:30, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ 25,808 bytes +4‎ →‎Reconstituted HDL Infusion
• curprev 13:2613:26, 20 September 2013‎ Hilda Mahmoudi talk contribs‎ 25,804 bytes +105‎ →‎Reconstituted HDL Infusion

19 September 2013

• curprev 19:4419:44, 19 September 2013‎ Rim Halaby talk contribs‎ 25,699 bytes +11‎ →‎Reconstituted HDL Infusion
• curprev 18:4718:47, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 25,688 bytes −9‎ →‎CETP Inhibitors
• curprev 18:4518:45, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 25,697 bytes −18‎ No edit summary
• curprev 18:4218:42, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 25,715 bytes +18‎ →‎CETP Inhibitors
• curprev 18:3818:38, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 25,697 bytes −6‎ →‎CETP Inhibitors
• curprev 18:2818:28, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 25,703 bytes +362‎ →‎CETP Inhibitors
• curprev 18:2318:23, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 25,341 bytes +362‎ →‎CETP Inhibitors
• curprev 18:1918:19, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 24,979 bytes +1,608‎ →‎CETP Inhibitors
• curprev 18:0418:04, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 23,371 bytes +791‎ →‎CETP Inhibitors
• curprev 17:2017:20, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 22,580 bytes +66‎ →‎CETP Inhibitors
• curprev 17:1717:17, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 22,514 bytes +12‎ →‎CETP Inhibitors
• curprev 17:1517:15, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 22,502 bytes +971‎ →‎CETP Inhibitors
• curprev 16:2016:20, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 21,531 bytes +1,738‎ →‎CETP Inhibitors
• curprev 16:1316:13, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 19,793 bytes +407‎ →‎CETP Inhibitors
• curprev 16:0916:09, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 19,386 bytes +1,184‎ →‎CETP Inhibitors
• curprev 16:0316:03, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 18,202 bytes +2,186‎ →‎CETP Inhibitors
• curprev 15:4815:48, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 16,016 bytes +520‎ →‎CETP Inhibitors
• curprev 15:4215:42, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 15,496 bytes +350‎ →‎CETP Inhibitors
• curprev 15:3815:38, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 15,146 bytes +134‎ →‎CETP Inhibitors
• curprev 15:3615:36, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 15,012 bytes 0‎ →‎CETP Inhibitors
• curprev 15:3515:35, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 15,012 bytes +22‎ →‎CETP Inhibitors
• curprev 15:1515:15, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 14,990 bytes −11‎ →‎CETP Inhibitors
• curprev 15:0915:09, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 15,001 bytes +6‎ →‎CETP Inhibitors
• curprev 14:5714:57, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 14,995 bytes −6‎ No edit summary
• curprev 14:5214:52, 19 September 2013‎ Rim Halaby talk contribs‎ m 15,001 bytes 0‎ Rim Halaby moved page High density lipoprotein landmark trials to High density lipoprotein complete list of trials
• curprev 14:4814:48, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 15,001 bytes 0‎ →‎CETP Inhibitors
• curprev 14:3514:35, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 15,001 bytes −22‎ No edit summary
• curprev 14:3414:34, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 15,023 bytes +1‎ No edit summary
• curprev 14:1214:12, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 15,022 bytes +120‎ →‎CETP Inhibitors
• curprev 14:0914:09, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 14,902 bytes +3,452‎ →‎CETP Inhibitors
• curprev 13:3513:35, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 11,450 bytes −650‎ →‎Other trials
• curprev 13:3413:34, 19 September 2013‎ Hilda Mahmoudi talk contribs‎ 12,100 bytes +698‎ →‎CETP Inhibitors

18 September 2013

• curprev 20:4720:47, 18 September 2013‎ Hilda Mahmoudi talk contribs‎ 11,402 bytes +187‎ →‎Reconstituted HDL Infusion
• curprev 20:3520:35, 18 September 2013‎ Hilda Mahmoudi talk contribs‎ 11,215 bytes −1‎ →‎CETP Inhibitors
• curprev 20:3420:34, 18 September 2013‎ Hilda Mahmoudi talk contribs‎ 11,216 bytes −105‎ →‎CETP Inhibitors
• curprev 20:3020:30, 18 September 2013‎ Hilda Mahmoudi talk contribs‎ 11,321 bytes −1‎ →‎CETP Inhibitors
• curprev 20:2520:25, 18 September 2013‎ Hilda Mahmoudi talk contribs‎ 11,322 bytes +2,257‎ →‎CETP Inhibitors
• curprev 20:0620:06, 18 September 2013‎ Hilda Mahmoudi talk contribs‎ 9,065 bytes +49‎ →‎CETP Inhibitors
• curprev 20:0320:03, 18 September 2013‎ Rim Halaby talk contribs‎ 9,016 bytes +17‎ →‎Reconstituted HDL Infusion
• curprev 20:0220:02, 18 September 2013‎ Rim Halaby talk contribs‎ 8,999 bytes +104‎ No edit summary
• curprev 19:5919:59, 18 September 2013‎ Hilda Mahmoudi talk contribs‎ 8,895 bytes +37‎ →‎CETP Inhibitors
• curprev 19:5319:53, 18 September 2013‎ Hilda Mahmoudi talk contribs‎ 8,858 bytes +26‎ →‎CETP Inhibitors
• curprev 19:4219:42, 18 September 2013‎ Hilda Mahmoudi talk contribs‎ 8,832 bytes +2‎ →‎CETP Inhibitors
• curprev 19:3719:37, 18 September 2013‎ Rim Halaby talk contribs‎ 8,830 bytes +52‎ →‎CETP Inhibitors
• curprev 19:3419:34, 18 September 2013‎ Rim Halaby talk contribs‎ 8,778 bytes +11‎ →‎CETP Inhibitors
• curprev 19:1819:18, 18 September 2013‎ Rim Halaby talk contribs‎ 8,767 bytes +1‎ →‎CETP Inhibitors
• curprev 19:1719:17, 18 September 2013‎ Rim Halaby talk contribs‎ 8,766 bytes +21‎ →‎CETP Inhibitors
• curprev 19:1119:11, 18 September 2013‎ Rim Halaby talk contribs‎ 8,745 bytes +1,531‎ →‎CETP Inhibitors
• curprev 19:0019:00, 18 September 2013‎ Rim Halaby talk contribs‎ 7,214 bytes +812‎ →‎Other trials
• curprev 18:5718:57, 18 September 2013‎ Rim Halaby talk contribs‎ 6,402 bytes +442‎ →‎CETP Inhibitors
• curprev 18:5318:53, 18 September 2013‎ Rim Halaby talk contribs‎ 5,960 bytes −2‎ →‎Other trials
• curprev 18:5318:53, 18 September 2013‎ Rim Halaby talk contribs‎ 5,962 bytes +3‎ →‎Other trials
• curprev 18:5318:53, 18 September 2013‎ Rim Halaby talk contribs‎ 5,959 bytes +724‎ →‎Other trials
• curprev 18:4818:48, 18 September 2013‎ Rim Halaby talk contribs‎ 5,235 bytes +37‎ →‎Other trials
• curprev 18:4718:47, 18 September 2013‎ Rim Halaby talk contribs‎ 5,198 bytes +866‎ →‎CETP Inhibitors
• curprev 17:5217:52, 18 September 2013‎ Rim Halaby talk contribs‎ 4,332 bytes +370‎ →‎CETP Inhibitors
• curprev 17:4717:47, 18 September 2013‎ Rim Halaby talk contribs‎ 3,962 bytes +13‎ →‎CETP Inhibitors
• curprev 17:4517:45, 18 September 2013‎ Rim Halaby talk contribs‎ 3,949 bytes +13‎ →‎CETP Inhibitors
• curprev 17:4417:44, 18 September 2013‎ Rim Halaby talk contribs‎ 3,936 bytes +105‎ →‎CETP Inhibitors
• curprev 17:4117:41, 18 September 2013‎ Rim Halaby talk contribs‎ 3,831 bytes +98‎ →‎CETP Inhibitors
• curprev 17:4117:41, 18 September 2013‎ Rim Halaby talk contribs‎ 3,733 bytes +109‎ →‎CETP Inhibitors
• curprev 17:2317:23, 18 September 2013‎ Rim Halaby talk contribs‎ 3,624 bytes +272‎ →‎Other trials
• curprev 17:2017:20, 18 September 2013‎ Rim Halaby talk contribs‎ 3,352 bytes +3‎ →‎Other trials
• curprev 17:2017:20, 18 September 2013‎ Rim Halaby talk contribs‎ 3,349 bytes +123‎ →‎Other trials
• curprev 17:1817:18, 18 September 2013‎ Rim Halaby talk contribs‎ 3,226 bytes +3‎ →‎Other trials
• curprev 17:1717:17, 18 September 2013‎ Rim Halaby talk contribs‎ 3,223 bytes +378‎ No edit summary
• curprev 17:1417:14, 18 September 2013‎ Rim Halaby talk contribs‎ 2,845 bytes +11‎ →‎CETP Inhibitors
• curprev 17:1317:13, 18 September 2013‎ Rim Halaby talk contribs‎ 2,834 bytes +157‎ →‎CETP Inhibitors
• curprev 16:5016:50, 18 September 2013‎ Rim Halaby talk contribs‎ 2,677 bytes 0‎ →‎Reconstituted HDL Infusion
• curprev 16:4916:49, 18 September 2013‎ Rim Halaby talk contribs‎ 2,677 bytes +191‎ →‎Reconstituted HDL Infusion
• curprev 16:4116:41, 18 September 2013‎ Rim Halaby talk contribs‎ 2,486 bytes +301‎ →‎Reconstituted HDL Infusion
• curprev 16:3516:35, 18 September 2013‎ Rim Halaby talk contribs‎ 2,185 bytes +22‎ →‎Reconstituted HDL Infusion
• curprev 16:3316:33, 18 September 2013‎ Rim Halaby talk contribs‎ 2,163 bytes +9‎ →‎Reconstituted HDL Infusion
• curprev 16:3016:30, 18 September 2013‎ Rim Halaby talk contribs‎ 2,154 bytes +11‎ →‎Reconstituted HDL Infusion
• curprev 16:2216:22, 18 September 2013‎ Rim Halaby talk contribs‎ 2,143 bytes +27‎ →‎Reconstituted HDL Infusion
• curprev 16:1916:19, 18 September 2013‎ Rim Halaby talk contribs‎ 2,116 bytes +50‎ →‎Reconstituted HDL Infusion
• curprev 16:1416:14, 18 September 2013‎ Rim Halaby talk contribs‎ 2,066 bytes +146‎ →‎Reconstituted HDL Infusion
• curprev 16:0516:05, 18 September 2013‎ Rim Halaby talk contribs‎ 1,920 bytes +217‎ →‎Reconstituted HDL Infusion
• curprev 16:0316:03, 18 September 2013‎ Rim Halaby talk contribs‎ 1,703 bytes −24‎ →‎Reconstituted HDL Infusion
• curprev 16:0316:03, 18 September 2013‎ Rim Halaby talk contribs‎ 1,727 bytes +24‎ →‎Reconstituted HDL Infusion
• curprev 16:0116:01, 18 September 2013‎ Rim Halaby talk contribs‎ 1,703 bytes +210‎ →‎Reconstituted HDL Infusion
• curprev 15:5915:59, 18 September 2013‎ Rim Halaby talk contribs‎ 1,493 bytes +240‎ →‎Reconstituted HDL Infusion
• curprev 15:3815:38, 18 September 2013‎ Rim Halaby talk contribs‎ 1,253 bytes +23‎ →‎CETP Inhibitors
• curprev 15:3815:38, 18 September 2013‎ Rim Halaby talk contribs‎ 1,230 bytes +17‎ →‎Reconstituted HDL Infusion
• curprev 11:4711:47, 18 September 2013‎ Rim Halaby talk contribs‎ 1,213 bytes 0‎ →‎CETP Inhibitors
• curprev 02:5302:53, 18 September 2013‎ Rim Halaby talk contribs‎ 1,213 bytes +22‎ →‎CETP Inhibitors
• curprev 00:2700:27, 18 September 2013‎ Rim Halaby talk contribs‎ 1,191 bytes +241‎ No edit summary
• curprev 00:2300:23, 18 September 2013‎ Rim Halaby talk contribs‎ 950 bytes +34‎ No edit summary
• curprev 00:2100:21, 18 September 2013‎ Rim Halaby talk contribs‎ 916 bytes 0‎ →‎Reconstituted HDL Infusion
• curprev 00:2000:20, 18 September 2013‎ Rim Halaby talk contribs‎ 916 bytes +17‎ →‎CETP Inhibitors
• curprev 00:1900:19, 18 September 2013‎ Rim Halaby talk contribs‎ 899 bytes +14‎ →‎Reconstituted HDL Infusion
• curprev 00:1200:12, 18 September 2013‎ Rim Halaby talk contribs‎ 885 bytes +73‎ →‎Fibrate
• curprev 00:1000:10, 18 September 2013‎ Rim Halaby talk contribs‎ 812 bytes +196‎ →‎Niacin
• curprev 00:0800:08, 18 September 2013‎ Rim Halaby talk contribs‎ 616 bytes +165‎ →‎Reconstituted HDL Infusion
• curprev 00:0500:05, 18 September 2013‎ Rim Halaby talk contribs‎ 451 bytes +10‎ →‎CETP Inhibitors
• curprev 00:0400:04, 18 September 2013‎ Rim Halaby talk contribs‎ 441 bytes −1‎ No edit summary
• curprev 00:0400:04, 18 September 2013‎ Rim Halaby talk contribs‎ 442 bytes +1‎ →‎DAL-outcomes Trial
• curprev 00:0300:03, 18 September 2013‎ Rim Halaby talk contribs‎ 441 bytes +133‎ →‎Reconstituted HDL Infusion
• curprev 00:0100:01, 18 September 2013‎ Rim Halaby talk contribs‎ 308 bytes −84,559‎ Replaced content with "__NOTOC__ {{High density lipoprotein}} {{CMG}}; {{AE}} {{AN}}; {{RT}} ==Reconstituted HDL Infusion== ==CETP Inhibitors== ==Niacin== ==Fibrate== {{Lipopedia}} Categ..."

16 September 2013

• curprev 21:3421:34, 16 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 84,867 bytes +708‎ No edit summary
• curprev 20:4520:45, 16 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 84,159 bytes +326‎ No edit summary
• curprev 20:3420:34, 16 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 83,833 bytes +1,277‎ No edit summary
• curprev 19:5419:54, 16 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 82,556 bytes +506‎ No edit summary

13 September 2013

• curprev 12:2612:26, 13 September 2013‎ Rim Halaby talk contribs‎ 82,050 bytes +39‎ No edit summary

11 September 2013

• curprev 12:4112:41, 11 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 82,011 bytes +27‎ →‎Objective
• curprev 12:1012:10, 11 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 81,984 bytes −4‎ →‎Objective

10 September 2013

• curprev 22:1222:12, 10 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 81,988 bytes 0‎ →‎Methods
• curprev 21:5021:50, 10 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 81,988 bytes +101‎ →‎Results
• curprev 21:3521:35, 10 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 81,887 bytes +104‎ →‎Conclusion
• curprev 21:2021:20, 10 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 81,783 bytes +44‎ →‎AIM-HIGH Trial
• curprev 20:4320:43, 10 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 81,739 bytes +24‎ →‎Methods
• curprev 20:3620:36, 10 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 81,715 bytes +82‎ →‎Results
• curprev 20:3120:31, 10 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 81,633 bytes +42‎ →‎Methods
• curprev 19:5419:54, 10 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 81,591 bytes +21‎ →‎Objective
• curprev 19:4619:46, 10 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 81,570 bytes +9‎ →‎Methods
• curprev 19:4319:43, 10 September 2013‎ Ayokunle Olubaniyi talk contribs‎ 81,561 bytes −176‎ No edit summary

31 July 2013

• curprev 03:0003:00, 31 July 2013‎ Rim Halaby talk contribs‎ 81,737 bytes +1‎ →‎Method
• curprev 02:5902:59, 31 July 2013‎ Rim Halaby talk contribs‎ 81,736 bytes −1‎ →‎Results=
• curprev 02:5802:58, 31 July 2013‎ Rim Halaby talk contribs‎ 81,737 bytes +6‎ →‎AVERT Trial
• curprev 02:5402:54, 31 July 2013‎ Rim Halaby talk contribs‎ 81,731 bytes +98‎ →‎CARE Trial
• curprev 02:4402:44, 31 July 2013‎ Rim Halaby talk contribs‎ 81,633 bytes +87‎ →‎SCAT Trial
• curprev 02:2402:24, 31 July 2013‎ Rim Halaby talk contribs‎ 81,546 bytes −5‎ /* SCAT Trial{{cite journal |author=Teo KK, Burton JR, Buller CE, et al. |title=Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial...
• curprev 02:2202:22, 31 July 2013‎ Rim Halaby talk contribs‎ 81,551 bytes +1‎ →‎FATS Trial
• curprev 02:1802:18, 31 July 2013‎ Rim Halaby talk contribs‎ 81,550 bytes +97‎ No edit summary

30 July 2013

• curprev 16:0116:01, 30 July 2013‎ Rim Halaby talk contribs‎ 81,453 bytes +115‎ /* HATS Trial{{cite journal |author=Brown BG, Zhao XQ, Chait A, et al. |title=Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease |journal=The New England Journal of Medicine |volume=345 |issue=22 |pa...
• curprev 15:4815:48, 30 July 2013‎ Rim Halaby talk contribs‎ 81,338 bytes +602‎ /* VA-HIT Trial{{cite journal |author=Robins SJ, Collins D, Nelson JJ, Bloomfield HE, Asztalos BF |title=Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs H...
• curprev 15:1115:11, 30 July 2013‎ Rim Halaby talk contribs‎ 80,736 bytes +1‎ /* VA-HIT Trial{{cite journal |author=Robins SJ, Collins D, Nelson JJ, Bloomfield HE, Asztalos BF |title=Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs H...

3 May 2013

• curprev 15:0115:01, 3 May 2013‎ Michael Maddaleni talk contribs‎ 80,735 bytes −1‎ /* SPARCL Study{{cite journal |author=Amarenco P, Bogousslavsky J, Callahan A, et al. |title=High-dose atorvastatin after stroke or transient ischemic attack |journal=The New England Journal of Medicine |volume=355 |issue=6 |pages=549–59 |year=2...
• curprev 15:0115:01, 3 May 2013‎ Michael Maddaleni talk contribs‎ 80,736 bytes 0‎ →‎Evacetrapib
• curprev 15:0015:00, 3 May 2013‎ Michael Maddaleni talk contribs‎ 80,736 bytes 0‎ →‎Evacetrapib
• curprev 14:5814:58, 3 May 2013‎ Michael Maddaleni talk contribs‎ 80,736 bytes 0‎ →‎Dalcetrapib
• curprev 14:5714:57, 3 May 2013‎ Michael Maddaleni talk contribs‎ 80,736 bytes 0‎ →‎CETP Inhibitors
• curprev 14:4714:47, 3 May 2013‎ Michael Maddaleni talk contribs‎ 80,736 bytes +6‎ /* AFREGS Trial{{cite journal |author=Whitney EJ, Krasuski RA, Personius BE, et al. |title=A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical e...
• curprev 14:4314:43, 3 May 2013‎ Michael Maddaleni talk contribs‎ 80,730 bytes +7‎ /* Phase Z of A-Z Trial{{cite journal |author=de Lemos JA, Blazing MA, Wiviott SD, et al. |title=Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial |journal=JAMA : ...
• curprev 14:3914:39, 3 May 2013‎ Michael Maddaleni talk contribs‎ 80,723 bytes +10‎ /* Phase Z of A-Z Trial{{cite journal |author=de Lemos JA, Blazing MA, Wiviott SD, et al. |title=Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial |journal=JAMA : ...
• curprev 13:5213:52, 3 May 2013‎ Michael Maddaleni talk contribs‎ 80,713 bytes +19‎ /* Heart Protection Study{{cite journal |author= |title=MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial |journal=Lancet |volume=360 |issue=9326 |pages=7...
• curprev 13:5013:50, 3 May 2013‎ Michael Maddaleni talk contribs‎ 80,694 bytes −7‎ /* Heart Protection Study{{cite journal |author= |title=MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial |journal=Lancet |volume=360 |issue=9326 |pages=7...

2 May 2013

• curprev 20:3120:31, 2 May 2013‎ Michael Maddaleni talk contribs‎ 80,701 bytes −2‎ /* SEARCH Study{{cite journal |author=Armitage J, Bowman L, Wallendszus K, et al. |title=Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial ...
• curprev 20:2620:26, 2 May 2013‎ Michael Maddaleni talk contribs‎ 80,703 bytes +1‎ /* IDEAL Trial{{cite journal |author=Pedersen TR, Faergeman O, Kastelein JJ, et al. |title=High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial |journ...
• curprev 20:2320:23, 2 May 2013‎ Michael Maddaleni talk contribs‎ 80,702 bytes +11‎ /* TNT Trial{{cite journal |author=Waters DD |title=Clinical insights from the Treating to New Targets trial |journal=Progress in Cardiovascular Diseases |volume=51 |issue=6 |pages=487–502 |year=2009 |pmid=19410683 |doi=10.1016/j.pcad.2009.01.00...
• curprev 20:1820:18, 2 May 2013‎ Michael Maddaleni talk contribs‎ 80,691 bytes +1‎ →‎SATURN Trial
• curprev 19:5719:57, 2 May 2013‎ Michael Maddaleni talk contribs‎ 80,690 bytes 0‎ /* HARP Study{{cite journal |author=Sacks FM, Pasternak RC, Gibson CM, Rosner B, Stone PH |title=Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. Harvard Atherosclerosis Reversi...
• curprev 19:4819:48, 2 May 2013‎ Michael Maddaleni talk contribs‎ 80,690 bytes −2‎ /* BECAIT Trial{{cite journal |author=Ruotolo G, Ericsson CG, Tettamanti C, et al. |title=Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progre...
• curprev 19:4519:45, 2 May 2013‎ Michael Maddaleni talk contribs‎ 80,692 bytes +1‎ /* REGRESS Trial{{cite journal |author=Jukema JW, Bruschke AV, van Boven AJ, et al. |title=Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated seru...
• curprev 19:3919:39, 2 May 2013‎ Michael Maddaleni talk contribs‎ 80,691 bytes +2‎ /* ARBITER 6-HALTS Trial{{cite journal |author=Taylor AJ, Villines TC, Stanek EJ, et al. |title=Extended-release niacin or ezetimibe and carotid intima-media thickness |journal=The New England Journal of Medicine |volume=361 |issue=22 |pages=2113...
• curprev 19:3119:31, 2 May 2013‎ Michael Maddaleni talk contribs‎ 80,689 bytes +12‎ /* ARBITER 3 Trial{{cite journal |author=Taylor AJ, Lee HJ, Sullenberger LE |title=The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3 |journal=Current Medical Research and Opinion...
• curprev 19:2219:22, 2 May 2013‎ Michael Maddaleni talk contribs‎ 80,677 bytes +1‎ /* AIM-HIGH Trial{{cite journal |author=Boden WE, Probstfield JL, Anderson T, et al. |title=Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy |journal=N. Engl. J. Med. |volume=365 |issue=24 |pages=2255–67 |yea...

26 April 2013

• curprev 20:1320:13, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 80,676 bytes −4‎ No edit summary
• curprev 20:1220:12, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 80,680 bytes +452‎ No edit summary
• curprev 15:2415:24, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 80,228 bytes +7‎ /* GAIN Trial{{cite journal |author=Schartl M, Bocksch W, Koschyk DH, et al. |title=Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary art...
• curprev 15:2315:23, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 80,221 bytes −1‎ /* GAIN Trial{{cite journal |author=Schartl M, Bocksch W, Koschyk DH, et al. |title=Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary art...
• curprev 15:1515:15, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 80,222 bytes +4‎ /* CLAS Trial{{cite journal |author=Cashin-Hemphill L, Mack WJ, Pogoda JM, Sanmarco ME, Azen SP, Blankenhorn DH |title=Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up |journal=JAMA |volume=264 |issue=23 |pag...
• curprev 15:0015:00, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 80,218 bytes −3‎ No edit summary
• curprev 14:5914:59, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 80,221 bytes −7‎ No edit summary
• curprev 14:5314:53, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 80,228 bytes 0‎ /* FLORIDA Trial{{cite journal |author=Liem AH, van Boven AJ, Veeger NJ, et al. |title=Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial |journal=European Heart Journal |volume=23 |issue=24 |pages=1931–...
• curprev 14:5114:51, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 80,228 bytes +5‎ /* Phase Z of A-Z Trial{{cite journal |author=de Lemos JA, Blazing MA, Wiviott SD, et al. |title=Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial |journal=JAMA : ...
• curprev 14:4614:46, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 80,223 bytes +70‎ /* AFREGS Trial{{cite journal |author=Whitney EJ, Krasuski RA, Personius BE, et al. |title=A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical e...
• curprev 14:4114:41, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 80,153 bytes +1‎ /* ARBITER 6-HALTS Trial{{cite journal |author=Taylor AJ, Villines TC, Stanek EJ, et al. |title=Extended-release niacin or ezetimibe and carotid intima-media thickness |journal=The New England Journal of Medicine |volume=361 |issue=22 |pages=2113...
• curprev 14:4014:40, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 80,152 bytes −1‎ /* ARBITER 6-HALTS Trial{{cite journal |author=Taylor AJ, Villines TC, Stanek EJ, et al. |title=Extended-release niacin or ezetimibe and carotid intima-media thickness |journal=The New England Journal of Medicine |volume=361 |issue=22 |pages=2113...
• curprev 14:3914:39, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 80,153 bytes +534‎ /* ARBITER 6-HALTS Trial{{cite journal |author=Taylor AJ, Villines TC, Stanek EJ, et al. |title=Extended-release niacin or ezetimibe and carotid intima-media thickness |journal=The New England Journal of Medicine |volume=361 |issue=22 |pages=2113...
• curprev 14:3414:34, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 79,619 bytes +161‎ /* ARBITER 6-HALTS Trial{{cite journal |author=Taylor AJ, Villines TC, Stanek EJ, et al. |title=Extended-release niacin or ezetimibe and carotid intima-media thickness |journal=The New England Journal of Medicine |volume=361 |issue=22 |pages=2113...
• curprev 14:2114:21, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 79,458 bytes +7‎ /* SPARCL Study{{cite journal |author=Amarenco P, Bogousslavsky J, Callahan A, et al. |title=High-dose atorvastatin after stroke or transient ischemic attack |journal=The New England Journal of Medicine |volume=355 |issue=6 |pages=549–59 |year=2...
• curprev 13:5713:57, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 79,451 bytes +95‎ /* CORONA Trial{{cite journal |author=Kjekshus J, Apetrei E, Barrios V, et al. |title=Rosuvastatin in older patients with systolic heart failure |journal=The New England Journal of Medicine |volume=357 |issue=22 |pages=2248–61 |year=2007 |month=...
• curprev 13:4113:41, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 79,356 bytes +44‎ /* ERASE Trial{{cite journal |author=Tardif JC, Grégoire J, L'Allier PL, et al. |title=Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial |journal=JAMA : the Journal of the Ameri...
• curprev 13:3613:36, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 79,312 bytes −6‎ No edit summary
• curprev 13:3513:35, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 79,318 bytes +19‎ /* Infusion of Apo A-1 Milano{{cite journal |author=Nissen SE, Tsunoda T, Tuzcu EM, et al. |title=Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial |journal=JAM...
• curprev 13:2813:28, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 79,299 bytes +6‎ /* Infusion of Apo A-1 Milano{{cite journal |author=Nissen SE, Tsunoda T, Tuzcu EM, et al. |title=Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial |journal=JAM...
• curprev 13:2513:25, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 79,293 bytes +5‎ /* Infusion of Apo A-1 Milano{{cite journal |author=Nissen SE, Tsunoda T, Tuzcu EM, et al. |title=Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial |journal=JAM...
• curprev 13:2413:24, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 79,288 bytes −13‎ →‎Anacetrapib
• curprev 13:2313:23, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 79,301 bytes −20‎ →‎Evacetrapib
• curprev 13:2113:21, 26 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 79,321 bytes +37‎ →‎Torcetrapib
• curprev 13:1513:15, 26 April 2013‎ Aarti Narayan talk contribs‎ 79,284 bytes −3‎ /* Infusion of Apo A-1 Milano{{cite journal |author=Nissen SE, Tsunoda T, Tuzcu EM, et al. |title=Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial |journal=JAM...
• curprev 13:1513:15, 26 April 2013‎ Aarti Narayan talk contribs‎ 79,287 bytes −21‎ →‎Torcetrapib
• curprev 13:1213:12, 26 April 2013‎ Aarti Narayan talk contribs‎ 79,308 bytes +1,002‎ →‎Evacetrapib
• curprev 13:0913:09, 26 April 2013‎ Aarti Narayan talk contribs‎ 78,306 bytes +422‎ →‎Dalcetrapib
• curprev 12:5212:52, 26 April 2013‎ Aarti Narayan talk contribs‎ 77,884 bytes +1,120‎ →‎Anacetrapib
• curprev 12:4512:45, 26 April 2013‎ Aarti Narayan talk contribs‎ 76,764 bytes +499‎ →‎Anacetrapib
• curprev 12:4412:44, 26 April 2013‎ Aarti Narayan talk contribs‎ 76,265 bytes +580‎ →‎Torcetrapib

25 April 2013

• curprev 20:4520:45, 25 April 2013‎ Aarti Narayan talk contribs‎ 75,685 bytes +685‎ /* Infusion of Apo A-1 Milano{{cite journal |author=Nissen SE, Tsunoda T, Tuzcu EM, et al. |title=Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial |journal=JAM...
• curprev 19:4719:47, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 75,000 bytes −4‎ /* VA-HIT Trial{{cite journal |author=Robins SJ, Collins D, Nelson JJ, Bloomfield HE, Asztalos BF |title=Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affa...
• curprev 19:4519:45, 25 April 2013‎ Aarti Narayan talk contribs‎ 75,004 bytes +1,282‎ /* CORONA Trial{{cite journal |author=Kjekshus J, Apetrei E, Barrios V, et al. |title=Rosuvastatin in older patients with systolic heart failure |journal=The New England Journal of Medicine |volume=357 |issue=22 |pages=2248–61 |year=2007 |month=...
• curprev 19:4319:43, 25 April 2013‎ Aarti Narayan talk contribs‎ 73,722 bytes +1,055‎ /* AVERT Trial{{cite journal |author=Pitt B, Waters D, Brown WV, et al. |title=Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators |journal=Th...
• curprev 19:2919:29, 25 April 2013‎ Aarti Narayan talk contribs‎ 72,667 bytes +354‎ /* SPARCL Study{{cite journal |author=Amarenco P, Bogousslavsky J, Callahan A, et al. |title=High-dose atorvastatin after stroke or transient ischemic attack |journal=The New England Journal of Medicine |volume=355 |issue=6 |pages=549–59 |year=2...
• curprev 19:2419:24, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 72,313 bytes +741‎ →‎AVERT Trial
• curprev 19:2319:23, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 71,572 bytes +24‎ →‎AVERT Trial
• curprev 19:2219:22, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 71,548 bytes −4‎ →‎AVERT Trial
• curprev 19:2219:22, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 71,552 bytes +1,116‎ →‎AVERT Trial
• curprev 19:2119:21, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 70,436 bytes −2‎ No edit summary
• curprev 19:2119:21, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 70,438 bytes +23‎ /* SPARCL Study (Stroke Prevention by Aggressive Reduction in Cholesterol Levels){{cite journal |author=Amarenco P, Bogousslavsky J, Callahan A, et al. |title=High-dose atorvastatin after stroke or transient ischemic attack |journal=The New Englan...
• curprev 19:2019:20, 25 April 2013‎ Aarti Narayan talk contribs‎ 70,415 bytes +689‎ /* SPARCL Study (Stroke Prevention by Aggressive Reduction in Cholesterol Levels){{cite journal |author=Amarenco P, Bogousslavsky J, Callahan A, et al. |title=High-dose atorvastatin after stroke or transient ischemic attack |journal=The New Englan...
• curprev 19:0119:01, 25 April 2013‎ Aarti Narayan talk contribs‎ 69,726 bytes +130‎ /* SPARCL Study (Stroke Prevention by Aggressive Reduction in Cholesterol Levels){{cite journal |author=Amarenco P, Bogousslavsky J, Callahan A, et al. |title=High-dose atorvastatin after stroke or transient ischemic attack |journal=The New Englan...
• curprev 18:3118:31, 25 April 2013‎ Aarti Narayan talk contribs‎ 69,596 bytes +459‎ /* ARBITER 6-HALTS Trial{{cite journal |author=Taylor AJ, Villines TC, Stanek EJ, et al. |title=Extended-release niacin or ezetimibe and carotid intima-media thickness |journal=The New England Journal of Medicine |volume=361 |issue=22 |pages=2113...
• curprev 17:2217:22, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 69,137 bytes +20‎ /* HATS Trial{{cite journal |author=Brown BG, Zhao XQ, Chait A, et al. |title=Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease |journal=The New England Journal of Medicine |volume=345 |issue=2...
• curprev 17:2017:20, 25 April 2013‎ Aarti Narayan talk contribs‎ 69,117 bytes +162‎ /* ARBITER 6-HALTS Trial{{cite journal |author=Taylor AJ, Villines TC, Stanek EJ, et al. |title=Extended-release niacin or ezetimibe and carotid intima-media thickness |journal=The New England Journal of Medicine |volume=361 |issue=22 |pages=2113...
• curprev 17:2017:20, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 68,955 bytes +366‎ →‎HATS Trial
• curprev 17:2017:20, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 68,589 bytes −7‎ →‎HATS Trial
• curprev 17:1917:19, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 68,596 bytes +298‎ →‎Trial of Simvastatin Plus Niacin
• curprev 17:1717:17, 25 April 2013‎ Aarti Narayan talk contribs‎ 68,298 bytes +615‎ /* ARBITER 6-HALTS Trial{{cite journal |author=Taylor AJ, Villines TC, Stanek EJ, et al. |title=Extended-release niacin or ezetimibe and carotid intima-media thickness |journal=The New England Journal of Medicine |volume=361 |issue=22 |pages=2113...
• curprev 17:0717:07, 25 April 2013‎ Aarti Narayan talk contribs‎ 67,683 bytes +643‎ /* ARBITER 6-HALTS Trial{{cite journal |author=Taylor AJ, Villines TC, Stanek EJ, et al. |title=Extended-release niacin or ezetimibe and carotid intima-media thickness |journal=The New England Journal of Medicine |volume=361 |issue=22 |pages=2113...
• curprev 16:5516:55, 25 April 2013‎ Aarti Narayan talk contribs‎ 67,040 bytes +386‎ /* AFREGS Trial{{cite journal |author=Whitney EJ, Krasuski RA, Personius BE, et al. |title=A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical e...
• curprev 16:3816:38, 25 April 2013‎ Aarti Narayan talk contribs‎ 66,654 bytes +237‎ /* AFREGS Trial{{cite journal |author=Whitney EJ, Krasuski RA, Personius BE, et al. |title=A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical e...
• curprev 16:3516:35, 25 April 2013‎ Aarti Narayan talk contribs‎ 66,417 bytes +266‎ /* AFREGS Trial{{cite journal |author=Whitney EJ, Krasuski RA, Personius BE, et al. |title=A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical e...
• curprev 16:3316:33, 25 April 2013‎ Aarti Narayan talk contribs‎ 66,151 bytes +224‎ /* AFREGS Trial{{cite journal |author=Whitney EJ, Krasuski RA, Personius BE, et al. |title=A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical e...
• curprev 16:3016:30, 25 April 2013‎ Aarti Narayan talk contribs‎ 65,927 bytes +3‎ /* AFREGS Trial{{cite journal |author=Whitney EJ, Krasuski RA, Personius BE, et al. |title=A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical e...
• curprev 16:2316:23, 25 April 2013‎ Aarti Narayan talk contribs‎ 65,924 bytes +594‎ /* AFREGS Trial{{cite journal |author=Whitney EJ, Krasuski RA, Personius BE, et al. |title=A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical e...
• curprev 15:4815:48, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 65,330 bytes +21‎ /* Phase Z of A-Z Trial{{cite journal |author=de Lemos JA, Blazing MA, Wiviott SD, et al. |title=Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial |journal=JAMA : ...
• curprev 15:4715:47, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 65,309 bytes +944‎ →‎Phase Z of A-Z Trial
• curprev 15:4515:45, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 64,365 bytes −7‎ →‎Phase Z of A-Z Trial
• curprev 15:4115:41, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 64,372 bytes +1,615‎ →‎Phase Z of A-Z Trial
• curprev 15:4015:40, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 62,757 bytes +1‎ No edit summary
• curprev 15:4015:40, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 62,756 bytes +27‎ No edit summary
• curprev 15:3915:39, 25 April 2013‎ Aarti Narayan talk contribs‎ 62,729 bytes +8‎ /* AFREGS Trial{{cite journal |author=Whitney EJ, Krasuski RA, Personius BE, et al. |title=A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical e...
• curprev 15:3615:36, 25 April 2013‎ Aarti Narayan talk contribs‎ 62,721 bytes +121‎ /* AFREGS Trial{{cite journal |author=Whitney EJ, Krasuski RA, Personius BE, et al. |title=A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical e...
• curprev 15:3515:35, 25 April 2013‎ Aarti Narayan talk contribs‎ 62,600 bytes +425‎ No edit summary
• curprev 15:2915:29, 25 April 2013‎ Aarti Narayan talk contribs‎ 62,175 bytes +11‎ /* Heart Protection Study{{cite journal |author= |title=MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial |journal=Lancet |volume=360 |issue=9326 |pages=7...
• curprev 15:2815:28, 25 April 2013‎ Aarti Narayan talk contribs‎ 62,164 bytes +312‎ /* Heart Protection Study{{cite journal |author= |title=MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial |journal=Lancet |volume=360 |issue=9326 |pages=7...
• curprev 15:2215:22, 25 April 2013‎ Aarti Narayan talk contribs‎ 61,852 bytes +802‎ /* Heart Protection Study{{cite journal |author= |title=MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial |journal=Lancet |volume=360 |issue=9326 |pages=7...
• curprev 15:0015:00, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 61,050 bytes +327‎ →‎FLORIDA Trial
• curprev 14:5614:56, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 60,723 bytes +20‎ →‎FLORIDA Trial
• curprev 14:5514:55, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 60,703 bytes −2‎ →‎FLORIDA Trial
• curprev 14:5514:55, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 60,705 bytes +143‎ →‎FLORIDA Trial
• curprev 14:5214:52, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 60,562 bytes +3‎ →‎FLORIDA Trial
• curprev 14:5114:51, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 60,559 bytes −2‎ →‎FLORIDA Trial
• curprev 14:5114:51, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 60,561 bytes +440‎ →‎FLORIDA Trial
• curprev 14:4414:44, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 60,121 bytes +8‎ →‎FLORIDA Trial
• curprev 14:4314:43, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 60,113 bytes +74‎ →‎FLORIDA Trial
• curprev 14:4214:42, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 60,039 bytes +141‎ →‎FLORIDA Trial
• curprev 14:3914:39, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 59,898 bytes +1‎ →‎FLORIDA Trial
• curprev 14:3914:39, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 59,897 bytes +364‎ →‎FLORIDA Trial
• curprev 14:3514:35, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 59,533 bytes +21‎ No edit summary
• curprev 14:2914:29, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 59,512 bytes −36‎ /* PROVE IT-TIMI 22 Trial{{cite journal |author=Cannon CP, Braunwald E, McCabe CH, et al. |title=Intensive versus moderate lipid lowering with statins after acute coronary syndromes |journal=The New England Journal of Medicine |volume=350 |issue=1...
• curprev 03:2603:26, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 59,548 bytes +6‎ /* PROVE IT-TIMI 22 Trial{{cite journal |author=Cannon CP, Braunwald E, McCabe CH, et al. |title=Intensive versus moderate lipid lowering with statins after acute coronary syndromes |journal=The New England Journal of Medicine |volume=350 |issue=1...
• curprev 03:2503:25, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 59,542 bytes −9‎ /* PROVE IT-TIMI 22 Trial{{cite journal |author=Cannon CP, Braunwald E, McCabe CH, et al. |title=Intensive versus moderate lipid lowering with statins after acute coronary syndromes |journal=The New England Journal of Medicine |volume=350 |issue=1...
• curprev 03:2403:24, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 59,551 bytes +546‎ /* PROVE IT-TIMI 22 Trial{{cite journal |author=Cannon CP, Braunwald E, McCabe CH, et al. |title=Intensive versus moderate lipid lowering with statins after acute coronary syndromes |journal=The New England Journal of Medicine |volume=350 |issue=1...
• curprev 03:2303:23, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 59,005 bytes +411‎ /* PROVE IT-TIMI 22 Trial{{cite journal |author=Cannon CP, Braunwald E, McCabe CH, et al. |title=Intensive versus moderate lipid lowering with statins after acute coronary syndromes |journal=The New England Journal of Medicine |volume=350 |issue=1...
• curprev 03:2303:23, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 58,594 bytes +527‎ /* PROVE IT-TIMI 22 Trial{{cite journal |author=Cannon CP, Braunwald E, McCabe CH, et al. |title=Intensive versus moderate lipid lowering with statins after acute coronary syndromes |journal=The New England Journal of Medicine |volume=350 |issue=1...
• curprev 03:2303:23, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 58,067 bytes +495‎ /* PROVE IT-TIMI 22 Trial{{cite journal |author=Cannon CP, Braunwald E, McCabe CH, et al. |title=Intensive versus moderate lipid lowering with statins after acute coronary syndromes |journal=The New England Journal of Medicine |volume=350 |issue=1...
• curprev 03:2203:22, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 57,572 bytes +353‎ →‎PROVE IT-TIMI 22 Trial
• curprev 03:2203:22, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 57,219 bytes 0‎ →‎PROVE IT-TIMI 22 Trial
• curprev 03:2103:21, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 57,219 bytes −6‎ →‎PROVE IT-TIMI 22 Trial
• curprev 03:2103:21, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 57,225 bytes +1,674‎ →‎PROVE IT-TIMI 22 Trial
• curprev 03:2103:21, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 55,551 bytes +1‎ No edit summary
• curprev 03:2003:20, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 55,550 bytes +29‎ No edit summary
• curprev 01:3701:37, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 55,521 bytes −1‎ /* MEGA Trial{{cite journal |author=Nakamura H, Arakawa K, Itakura H, et al. |title=Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial |journal=Lancet |volume=368 |issue=9...
• curprev 01:3501:35, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 55,522 bytes +860‎ →‎MIRACL Study
• curprev 01:3201:32, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 54,662 bytes +24‎ →‎MIRACL Study
• curprev 01:3101:31, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 54,638 bytes −5‎ →‎MIRACL Study
• curprev 01:3001:30, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 54,643 bytes +603‎ →‎MIRACL Study
• curprev 01:2901:29, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 54,040 bytes +609‎ →‎MIRACL Study
• curprev 01:2801:28, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 53,431 bytes +124‎ →‎MIRACL Study
• curprev 01:2801:28, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 53,307 bytes +1‎ No edit summary
• curprev 01:2701:27, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 53,306 bytes +19‎ No edit summary
• curprev 01:1201:12, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 53,287 bytes +6‎ /* MEGA Trial{{cite journal |author=Nakamura H, Arakawa K, Itakura H, et al. |title=Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial |journal=Lancet |volume=368 |issue=9...
• curprev 01:1101:11, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 53,281 bytes +727‎ →‎MEGA Trial
• curprev 01:1001:10, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 52,554 bytes +163‎ →‎MEGA Trial
• curprev 01:1001:10, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 52,391 bytes −4‎ →‎MEGA Trial
• curprev 01:1001:10, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 52,395 bytes +392‎ →‎MEGA Trial
• curprev 01:0901:09, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 52,003 bytes +479‎ →‎MEGA Trial
• curprev 01:0801:08, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 51,524 bytes −1‎ No edit summary
• curprev 01:0801:08, 25 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 51,525 bytes +193‎ No edit summary

24 April 2013

• curprev 20:3020:30, 24 April 2013‎ Aarti Narayan talk contribs‎ 51,332 bytes +470‎ /* Heart Protection Study{{cite journal |author= |title=MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial |journal=Lancet |volume=360 |issue=9326 |pages=7...
• curprev 19:3619:36, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 50,862 bytes +36‎ /* CARE Trial{{cite journal |author=Sacks FM, Pfeffer MA, Moye LA, et al. |title=The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investiga...
• curprev 19:3419:34, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 50,826 bytes +795‎ →‎CARE Trial
• curprev 19:3319:33, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 50,031 bytes −6‎ /* CARE Trial{{cite journal |author=Sacks FM, Pfeffer MA, Moye LA, et al. |title=The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investiga...
• curprev 19:3219:32, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 50,037 bytes +479‎ /* CARE Trial{{cite journal |author=Sacks FM, Pfeffer MA, Moye LA, et al. |title=The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investiga...
• curprev 19:2419:24, 24 April 2013‎ Aarti Narayan talk contribs‎ 49,558 bytes +374‎ /* CARE Trial{{cite journal |author=Sacks FM, Pfeffer MA, Moye LA, et al. |title=The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investiga...
• curprev 19:1319:13, 24 April 2013‎ Aarti Narayan talk contribs‎ 49,184 bytes +100‎ /* CARE Trial{{cite journal |author= |title=Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study |journal=Circulation |volume=102 |is...
• curprev 19:1219:12, 24 April 2013‎ Aarti Narayan talk contribs‎ 49,084 bytes +358‎ /* BIP Trial{{cite journal |author= |title=Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study |journal=Circulation |volume=102 |iss...
• curprev 19:0919:09, 24 April 2013‎ Aarti Narayan talk contribs‎ 48,726 bytes +338‎ /* BIP Trial{{cite journal |author= |title=Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study |journal=Circulation |volume=102 |iss...
• curprev 19:0519:05, 24 April 2013‎ Aarti Narayan talk contribs‎ 48,388 bytes +357‎ No edit summary
• curprev 18:5518:55, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 48,031 bytes +4‎ /* SEARCH Study{{cite journal |author=Armitage J, Bowman L, Wallendszus K, et al. |title=Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial ...
• curprev 18:5418:54, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 48,027 bytes +44‎ /* SEARCH Study{{cite journal |author=Armitage J, Bowman L, Wallendszus K, et al. |title=Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial ...
• curprev 18:5018:50, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 47,983 bytes +6‎ /* SEARCH Study{{cite journal |author=Armitage J, Bowman L, Wallendszus K, et al. |title=Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial ...
• curprev 18:5018:50, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 47,977 bytes +881‎ →‎SEARCH Study
• curprev 18:4818:48, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 47,096 bytes +232‎ →‎SEARCH Study
• curprev 18:3918:39, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 46,864 bytes +125‎ →‎SEARCH Study
• curprev 18:3718:37, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 46,739 bytes +112‎ →‎SEARCH Study
• curprev 18:3618:36, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 46,627 bytes −1‎ →‎SEARCH Study
• curprev 18:3518:35, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 46,628 bytes +270‎ →‎SEARCH Study
• curprev 18:2518:25, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 46,358 bytes +148‎ →‎SEARCH Study
• curprev 17:3917:39, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 46,210 bytes +11‎ →‎SEARCH Study
• curprev 17:3917:39, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 46,199 bytes +2‎ →‎SEARCH Study
• curprev 17:3817:38, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 46,197 bytes +147‎ →‎SEARCH Study
• curprev 17:3517:35, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 46,050 bytes +236‎ →‎SEARCH Study
• curprev 17:3317:33, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 45,814 bytes +151‎ →‎SEARCH Study
• curprev 17:2617:26, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 45,663 bytes +20‎ No edit summary
• curprev 17:1317:13, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 45,643 bytes +1‎ /* IDEAL Trial{{cite journal |author=Pedersen TR, Faergeman O, Kastelein JJ, et al. |title=High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial |journ...
• curprev 17:0017:00, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 45,642 bytes +16‎ /* IDEAL Trial{{cite journal |author=Pedersen TR, Faergeman O, Kastelein JJ, et al. |title=High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial |journ...
• curprev 16:5916:59, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 45,626 bytes +978‎ →‎IDEAL Trial
• curprev 16:5816:58, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 44,648 bytes +288‎ →‎IDEAL Trial
• curprev 16:5216:52, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 44,360 bytes +2‎ →‎IDEAL Trial
• curprev 16:5216:52, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 44,358 bytes +56‎ →‎IDEAL Trial
• curprev 16:4816:48, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 44,302 bytes −2‎ →‎IDEAL Trial
• curprev 16:4816:48, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 44,304 bytes +388‎ →‎IDEAL Trial
• curprev 16:4116:41, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 43,916 bytes +352‎ →‎IDEAL Trial
• curprev 16:3516:35, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 43,564 bytes +221‎ →‎IDEAL Trial
• curprev 16:3316:33, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 43,343 bytes −2‎ No edit summary
• curprev 16:3216:32, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 43,345 bytes +21‎ No edit summary
• curprev 15:5915:59, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 43,324 bytes +279‎ →‎TNT Trial
• curprev 15:5815:58, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 43,045 bytes +10‎ →‎TNT Trial
• curprev 15:5715:57, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 43,035 bytes +182‎ →‎TNT Trial
• curprev 15:5715:57, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 42,853 bytes −3‎ →‎TNT Trial
• curprev 15:5715:57, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 42,856 bytes +958‎ →‎TNT Trial
• curprev 15:3315:33, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 41,898 bytes +17‎ No edit summary
• curprev 14:5414:54, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 41,881 bytes +475‎ →‎LIPID Study
• curprev 14:5314:53, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 41,406 bytes +1,228‎ →‎LIPID Study
• curprev 14:4114:41, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 40,178 bytes +19‎ No edit summary
• curprev 14:3614:36, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 40,159 bytes +12‎ /* 4S Trial{{cite journal |author= |title=Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) |journal=Lancet |volume=344 |issue=8934 |pages=1383–9 |year=1994 |m...
• curprev 14:3514:35, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 40,147 bytes +307‎ →‎4S Trial
• curprev 14:3514:35, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 39,840 bytes +12‎ →‎4S Trial
• curprev 14:3414:34, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 39,828 bytes +407‎ →‎4S Trial
• curprev 14:2714:27, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 39,421 bytes +344‎ →‎4S Trial
• curprev 14:2414:24, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 39,077 bytes +152‎ →‎4S Trial
• curprev 14:2314:23, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 38,925 bytes +16‎ No edit summary
• curprev 13:3813:38, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 38,909 bytes +15‎ →‎SATURN Trial
• curprev 13:3813:38, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 38,894 bytes +304‎ →‎SATURN Trial
• curprev 13:3413:34, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 38,590 bytes −3‎ →‎SATURN Trial
• curprev 13:3413:34, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 38,593 bytes +323‎ →‎SATURN Trial
• curprev 13:2813:28, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 38,270 bytes +21‎ →‎SATURN Trial
• curprev 13:2713:27, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 38,249 bytes +181‎ →‎SATURN Trial
• curprev 13:2413:24, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 38,068 bytes +313‎ →‎SATURN Trial
• curprev 13:1513:15, 24 April 2013‎ Raviteja Reddy Guddeti talk contribs‎ 37,755 bytes +217‎ No edit summary